InvestorsHub Logo

vator

01/21/17 7:50 AM

#97353 RE: Extremist223 #97352

Probably one thing I agree with you. The IP alone is worth 5 to 10 more in market cap. DNDN assets just sold for $830 million.

HappyLibrarian

01/21/17 9:26 AM

#97365 RE: Extremist223 #97352

The fallback narrative for a Phase 3 failure is already being constructed? Interesting!

And a good try but if Phase 3 fails there will be nothing left of NWBO for shareholders whether they bothering selling who do not also own a piece of Cognate.

Failure or success will provide many shareholders a welcome sense of closure.

Attempts to drag out the misery in the event of a Phase 3 failure are just downright cruel.

Dan88

01/21/17 9:31 AM

#97366 RE: Extremist223 #97352

One should not read cannonblack's post literally. I don't think any investor would actually think it is 0-or-1 game. It is this long-played-out short scheme that toughens the mood and the reality as if we are readily faced with death or live situation.

It is a battle between controlling the price as low as possible while accumulate or to be more accurate cover as low as possible of those suspected huge numbers of naked short shares and trying to make any PR meaningfulness without experiencing any distortion, etc.

As pointed out, any PR at this stage if not earth-shattering in nature will be distorted. As a result, the share price would initially rise and then fall back. So why bother too much to do any PR in that nature. But rest assured, there will be PRS which are not earth-shattering in nature to be released, just no need to focused too much on it.

Instead the company should be focused on what is important to do while trying the utmost effort to conserve cash at this stage!

Ask this: The legally shorted shares have been almost covered so why there is no end of the usual relentless, absurd accusations, FUDs, distortion in regard of an almost nothing share price? The conclusion is that there is indeed a huge mountain of naked shorted shares out there sitting in MM and/or brokerages accounts.

These firms have disposed dedicated resources to combat share price, and in this matter try to bankrupt the company!

I have said before if our P3 trial outcomes were completely not favorable, the share price would initially drop further but it would quickly appreciate to its rightful place, to at least about $100 million or so market cap, equivalent to about $0.80 ~ $1 in today's price simply because of at least the following:

1) there are still multiple combo trials involving L and D with their importance gradually and steadily understood in the investment world;

2) German HE program would finally see its price negotiation settled although in a discount price compared to the situation with a successful p3 outcomes, and then the generation of some revenue;

3) very valuable IP portfolio.

We are not faced with a black and white situation, but instead there have been redlines drawn upon against each other by the utterly different camps.

Don't let your shares slip away; don't let your guard lower; and give Linda and the team some error margins because we are in a decisive battle together. For the long suffering we have endure, we ought to believe and we will win the battle on the very solid scientific and clinical ground that we have known and understood so far.

Good luck to true long and God bless the patients!